Related Experiment Video
Updated: Apr 21, 2026
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
CD1c+ blood dendritic cells have Langerhans cell potential
Paul Milne1, Venetia Bigley1, Merry Gunawan1
1Human Dendritic Cell Laboratory, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, United Kingdom.
Insights
Human monocytes can become Langerhans cells (LCs), but CD1c(+) dendritic cells (DCs) offer an alternative pathway. This study reveals a novel differentiation route for LCs, important for understanding immune cell regeneration.
Area of Science:
- Immunology
- Cell Biology
- Dermatology
Background:
- Langerhans cells (LCs) are crucial immune cells in the skin, capable of self-renewal but also repopulation by myeloid precursors post-injury.
- While human monocytes can differentiate into langerin-positive cells, suggesting a precursor role, alternative monocyte-independent pathways for LC differentiation have been proposed.
- Recent studies in mice indicate that myeloid precursors, distinct from monocytes, can repopulate the LC compartment long-term.
Purpose of the Study:
- To investigate the potential of CD1c(+) dendritic cells (DCs) as precursors for Langerhans cells (LCs).
- To identify alternative differentiation pathways for LCs beyond monocyte-derived routes.
- To elucidate the role of specific soluble ligands in promoting LC-like differentiation from dendritic cells.
Main Methods:
- In vitro differentiation experiments using human CD1c(+) dendritic cells (DCs).
- Culture of cells with specific soluble ligands: granulocyte macrophage colony-stimulating factor (GM-CSF), transforming growth factor β (TGFβ), and bone morphogenetic protein 7 (BMP7).
- Analysis of cell markers, including langerin, EpCAM, and E-cadherin, and assessment of Birbeck granules formation.
Main Results:
- Human monocytes express langerin but do not efficiently differentiate into LC-like cells under the tested conditions.
- CD1c(+) dendritic cells (DCs), when cultured with GM-CSF, TGFβ, and BMP7, exhibited significantly enhanced LC-like characteristics.
- These LC-like cells displayed high expression of langerin, formed Birbeck granules, and expressed EpCAM and E-cadherin, mimicking mature LCs.
Conclusions:
- CD1c(+) dendritic cells (DCs) represent a novel potential precursor population for Langerhans cells (LCs).
- This study demonstrates an alternative, monocyte-independent pathway for LC differentiation.
- These findings have potential implications for understanding immune cell regeneration and homeostasis in vivo.
Abstract:
Langerhans cells (LCs) are self-renewing in the steady state but repopulated by myeloid precursors after injury. Human monocytes give rise to langerin-positive cells in vitro, suggesting a potential precursor role. However, differentiation experiments with human lineage-negative cells and CD34(+) progenitors suggest that there is an alternative monocyte-independent pathway of LC differentiation. Recent data in mice also show long-term repopulation of the LC compartment with alternative myeloid precursors. Here we show that, although monocytes are able to express langerin, when cultured with soluble ligands granulocyte macrophage colony-stimulating factor (GM-CSF), transforming growth factor β (TGFβ), and bone morphogenetic protein 7 (BMP7), CD1c(+) dendritic cells (DCs) become much more LC-like with high langerin, Birbeck granules, EpCAM, and E-cadherin expression under the same conditions. These data highlight a new potential precursor function of CD1c(+) DCs and demonstrate an alternative pathway of LC differentiation that may have relevance in vivo.
